JPS5555114A - Fine drug - Google Patents

Fine drug

Info

Publication number
JPS5555114A
JPS5555114A JP13251079A JP13251079A JPS5555114A JP S5555114 A JPS5555114 A JP S5555114A JP 13251079 A JP13251079 A JP 13251079A JP 13251079 A JP13251079 A JP 13251079A JP S5555114 A JPS5555114 A JP S5555114A
Authority
JP
Japan
Prior art keywords
fine drug
drug
fine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13251079A
Other languages
English (en)
Japanese (ja)
Other versions
JPH024576B2 (enrdf_load_stackoverflow
Inventor
Aaru Betsuku Rii
Efu Furawaazu Chiyaaruzu
Aaru Kauzaa Donarudo
Shii Tankarii Arubaato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stolle Research and Development Corp
Original Assignee
Stolle Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Research and Development Corp filed Critical Stolle Research and Development Corp
Publication of JPS5555114A publication Critical patent/JPS5555114A/ja
Publication of JPH024576B2 publication Critical patent/JPH024576B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP13251079A 1978-10-17 1979-10-16 Fine drug Granted JPS5555114A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95210978A 1978-10-17 1978-10-17

Publications (2)

Publication Number Publication Date
JPS5555114A true JPS5555114A (en) 1980-04-22
JPH024576B2 JPH024576B2 (enrdf_load_stackoverflow) 1990-01-29

Family

ID=25492596

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13251079A Granted JPS5555114A (en) 1978-10-17 1979-10-16 Fine drug

Country Status (3)

Country Link
JP (1) JPS5555114A (enrdf_load_stackoverflow)
BE (1) BE879442A (enrdf_load_stackoverflow)
ZA (1) ZA795549B (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6450824A (en) * 1987-08-13 1989-02-27 Stolle Res & Dev Improved immunity for mammals
JPS6470044A (en) * 1987-08-20 1989-03-15 Hutchinson Sa Infection preventing device of elastomer and method for manufacture of the same
JP2001511773A (ja) * 1997-01-24 2001-08-14 フェムファーマ 薬学的調製物およびそれらの領域的投与のための方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6450824A (en) * 1987-08-13 1989-02-27 Stolle Res & Dev Improved immunity for mammals
JPS6470044A (en) * 1987-08-20 1989-03-15 Hutchinson Sa Infection preventing device of elastomer and method for manufacture of the same
JP2001511773A (ja) * 1997-01-24 2001-08-14 フェムファーマ 薬学的調製物およびそれらの領域的投与のための方法
JP2010138196A (ja) * 1997-01-24 2010-06-24 Femmepharma Holding Co Inc 薬学的調製物およびそれらの領域的投与のための方法

Also Published As

Publication number Publication date
ZA795549B (en) 1980-11-26
BE879442A (fr) 1980-04-16
JPH024576B2 (enrdf_load_stackoverflow) 1990-01-29

Similar Documents

Publication Publication Date Title
GB2085732B (en) Administration set
GB2039738B (en) Inflammation - preventing pharmaceutical composition
JPS5528986A (en) Novel administration form
BG27580A1 (en) Two- poled pelvis- thight articulation- set
GB2078771B (en) Drug carrier
GB2020655B (en) Pharmaceutical compounds
CS658879A2 (en) Viceproudovy stroj s tlakovymi vlnami plynu
JPS54157817A (en) Pharmaceutical prepared solution
GB1550308A (en) Syringes
JPS5542684A (en) Drug box
JPS54132563A (en) Corticosteroid antiiinflammatry drug
JPS54141797A (en) Therapeutic drug
JPS54154516A (en) Pharmaceutical composition
JPS54135795A (en) Diuretic drug
GB2028132B (en) Antifibrotic substance p-1894b
JPS5527168A (en) Drug composition
PT68889A (en) Ondocynetic teledynamic central
JPS5555114A (en) Fine drug
GB2012590B (en) Syringe
GB2056993B (en) Anorexogenic substance
GB2028660B (en) Administration set
CS771179A2 (en) Zpusob vyroby selektivne acylovaneho n chraneneho derivatu aminoglykosidoveho antibiotika
JPS5587718A (en) Medicine composition
JPS54122736A (en) Pharmaceutical composition
BG31541A1 (en) Ornitopter